Contraceptive R&D Sessions at ICFP
The International Conference on Family Planning (ICFP) will take place next week in Bogotá, Colombia from November 3-6 and contraceptive R&D is on the agenda. If you are interested in learning about the development of new contraceptive technologies and will be joining ICFP either in-person or virtually, here are the sessions to look out for:
Tuesday, November 4
Poster Session 1: Development of ADAM: a Long-Lasting, Non-Hormonal, and Reversible Male Contraceptive
Kevin Eisenfrats, Contraline, Inc.
10:00 - 11:30, Ágora Main Lobby-First Floor
Knowledge Exchange is Essential to Contraceptive Technology Innovation: Findings from the CTI Exchange Co-Creation Process
Emily Hoppes, CTI Exchange
11:55 - 13:15, Ágora Room B
Poster Session 2: Early Menstrual Induction: A proof-of-concept study on a post-fertilization fertility regulation method with a combination of levonorgestrel and mifepristone
Petra Procter, Concept Foundation
12:00 - 13:30, Ágora Main Lobby-First Floor
POSTER SESSION 3: Motivations to use a novel hormonal male contraceptive: Perspectives from male contraceptive clinical trial participants
Jessica Gipson, UCLA Fielding School Of Public Health
14:00 - 15:30, Ágora Main Lobby-First Floor
Stakeholder engagement to inform new contraceptive development and introduction
14:45 - 16:05, Ágora Room H
- Preferences for new contraceptive methods among women and adolescent girls in Malawi: Perspectives on emergency and on-demand oral contraceptive pills, Grace Jaworski, PSI
- Evaluating Demand for On-Demand Contraceptive Pills: Insights into Women’s Preferences in India, Marthe Zeldenrust, Amsterdam University Medical Center
- “No more abdominal cramps, no more excessive bleeding, everything is being regulated, so they love it so much”: Learnings on heavy menstrual bleeding and HIUD from a multi-country mixed methods study on HIUD introduction, Audrey Fratus, FHI 360
- Clinicians’ Perspectives on Considerations for the Introduction of a Self-care Contraceptive Vaginal Ring in Kenya’s Public Health Sector, Serah Gitome, Centre For Microbiology Research, Kenya Medical Research Institute
- High acceptability of intravaginal rings (IVRs) among male partners enrolled in a crossover study of 3 different sizes of non-medicated IVRs in the United States, Barbara Friedland, Population Council
ReproTank: The Next Gen Contraceptive Pitch-Off, Population Council
19:00 - 21:00, Room A
Mix, Mingle, and Mobilize: Join Bayer for an Evening Networking Session
19:00 - 21:00, Ágora Room J
Wednesday, November 5
Next-Gen Contraceptives: Science, Access, and Equity
Dr. Ru-fong Cheng, Gates Foundation; Christopher Purdy, DKT International; Dr. Frank Strelow, Bayer AG; Prof. Soniya Nityanand, King George's Medical University
10:20 - 11:40, Ágora Room VW
Poster Session 6:Low-dose Mifepristone for Emergency Contraception: Untapped Potential, Timely Opportunity
Petra Procter, Concept Foundation
12:00 - 13:30, Ágora Main Lobby-First Floor
Poster Session 7: Strategic Actions to Advance Multipurpose Prevention Technologies (MPTs) for contraception and prevention of HIV and/or other STIs
Bethany Young Holt, CAMI Health
14:00 - 15:30, Ágora Main Lobby-First Floor
Poster Session 8: Acceptability of an on-demand pericoital oral contraceptive pill: a systematic scoping review
Abi Winskell, PSI
16:00 - 17:30, Ágora Main Lobby-First Floor
The Exchange: What’s Exciting the Experts About Contraceptive Science
Emily Hoppes, CTI Exchange, Kevin Eisenfrats, Contraline, Carolina Sales Vieira, Universidade de São Paulo
17:15 - 17:25, LIVE Stage (Virtual)
Thursday, November 6
The Dual Prevention Pill Introduction Plan: Both a Question and an Answer to Integration
Wawira Nyagah, AVAC; Nelia Banda, Clinton Health Access Initiative (CHAI); Lori Miller, International Planned Parenthood Federation (IPPF); Kate Segal, AVAC; Rhoda Msiska, Copper Rose Zambia
10:20 – 11:40